Recombinant CD22 (Pinatuzumab Biosimilar) antibody

Catalog No. ABIN7488016

The Mammalian Cells Monoclonal anti-CD22 (Pinatuzumab Biosimilar) antibody has been validated for . It is suitable to detect CD22 (Pinatuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD22 (Pinatuzumab Biosimilar) antibody (ABIN7488016)

Target: CD22 (Pinatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This CD22 (Pinatuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD22 (Pinatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Pinatuzumab Biosimilar - Anti-CD22 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD22 (Pinatuzumab Biosimilar)

Target: CD22 (Pinatuzumab Biosimilar)

Target Type: Biosimilar

Background: ACD22-VCMMAE,DCDT2980S,FCU2803,RG-7593,RO5541072-000